retatrutide trial results news today This is exciting. 👀 The TRIUMPH-4 for Lilly's investigational medication were released, showing weight loss of up to 71 lbs (~28%) over 68 weeks in the highest-dose group—far New Phase 3 retatrutide data

[8] - [11] Neuromodulatory DSIP could help to compensate pathological metabolic damage in various animal species and humans, that is caused by oxygen deprivation in the body, preserving normal mitochondrial function and protecting tissue until proper blood flow is restored

The liver uses glutathione to bind to toxins, making them water-soluble so the body can safely flush them out

Often referred to as the master antioxidant, this essential compound plays a key role in detoxification, immune defense, and cellular health

Study, Patient, and procedural characteristics 41,800 patients in GLP-1 RA group and 36,902 patients in control group were included with a mean follow up of 21 months (1248 months)